Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.5.0.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance at Sep. 30, 2014 $ (6,892,443) $ 72,051 $ 5,810,200 $ (12,774,694)
Beginning balance (in shares) at Sep. 30, 2014   72,051,487    
Net loss (2,947,526) $ 0 0 (2,947,526)
Issuance of restricted stock for services 166,157 $ 475 165,682 0
Issuance of restricted stock for services (in shares)   475,000    
Reclassification of Series A and C Warrants 3,263,753 $ 0 3,263,753 0
Shares issued for the exercise of warrants 3,600,000 $ 18,687 3,581,313 0
Shares issued for the exercise of warrants (in shares)   18,686,801    
Shares issued for the exercise of stock options 0 $ 462 (462) 0
Shares issued for the exercise of stock options (in shares)   462,298    
Shares issued in consideration for extending the Series C Warrants and eliminating the Ratchet Provision 135,352 $ 570 134,782 0
Shares issued in consideration for extending the Series C Warrants and eliminating the Ratchet Provision (in shares)   570,000    
Issuance of stock in private placement funding 3,015,966 $ 14,391 3,001,575 0
Issuance of stock in private placement funding (in shares)   14,390,754    
Shares issued for the conversion of the convertible notes 151,173 $ 756 150,417 0
Shares issued for the conversion of the convertible notes (in shares)   755,865    
Stock based compensation expense 1,047,685 $ 0 1,047,685 0
Ending balance at Sep. 30, 2015 1,540,117 $ 107,392 17,154,945 (15,722,220)
Ending balance (in shares) at Sep. 30, 2015   107,392,205    
Net loss (5,992,370) $ 0 0 (5,992,370)
Issuance of restricted stock for services 52,500 $ 150 52,350 0
Issuance of restricted stock for services (in shares)   150,000    
Shares issued for the exercise of warrants 2,708,749 $ 11,845 2,696,904 0
Shares issued for the exercise of warrants (in shares)   11,844,516    
Shares issued for the exercise of stock options $ 0 $ 69 (69) 0
Shares issued for the exercise of stock options (in shares) 362,500 68,967    
Exercise of Series A Warrants Cashless $ 0 $ 2,334 (2,334) 0
Exercise of Series A Warrants Cashless (in shares)   2,333,559    
Issuance of stock in private placement funding 3,108,939 $ 9,418 3,099,521 0
Issuance of stock in private placement funding (in shares)   9,418,334    
Shares issued for the conversion of the convertible notes 644,900 $ 3,224 641,676 0
Shares issued for the conversion of the convertible notes (in shares)   3,224,494    
Stock based compensation expense 1,098,160 $ 0 1,098,160 0
Ending balance at Sep. 30, 2016 $ 3,160,995 $ 134,432 $ 24,741,153 $ (21,714,590)
Ending balance (in shares) at Sep. 30, 2016   134,432,075